Диагностическое значение магнитно-резонансной томографии при гипертрофии миокарда левого желудочка различного генеза
Диссертация
Тем не менее, остается дискутабельным вопрос использования МРТ с отсроченным контрастированием для оценки риска внезапной сердечной смерти, которая является одним из самых грозных осложнений ГКМП. За последние годы за рубежом был проведен ряд исследований, посвященных изучению связи характера и объема контрастирования у пациентов с ГКМП и различных факторов, таких как объемные показатели ЛЖ, ММ… Читать ещё >
Список литературы
- Беленков Ю.Н., Привалова Е. В., Каплунова В. Ю., Стамбольский Д. В., Фомин А. А. Гипертрофическая кардиомиопатия исторические и современные взгляды на диагностику заболевания //Кардиология и сердечно-сосудистая хирургия, — 2008.- № 4. — С. 4−10.
- Беленков Ю.Н., Терновой С. К., Синицын В. Е. Магнитно-резонансная томография сердца и сосудов //М. Видар. — 1997. — С. 142.
- Грамович В.В., Синицын В. Е., Гордин М. П. и соавт. Количественная оценка перфузии миокарда с помощью магнитно-резонансной томографии//Кардиология.- 2004.- № 8. С. 4−12.
- Ринкк П.А. Магнитный резонанс в медицине //М.- Геотар-Мед. 2003.
- Синицын В.Е., Терновой С.К.. Магнитно-резонансная- томография в новом столетии //Радиология-практика.- 2005.- № 4. С. 17−22.
- Amano Y., Takayama M., Amano M., Kumazaki T. MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy //AJR Am J Roentgenol.- 2004.- Vol. 182. P. 523−527.
- Andersen К., Hennersdorf M., Cohnen M., Blondin D., Modder U., Poll L.W. Myocardial delayed contrast enhancement in patients with arterial hypertension: Initial results of cardiac MRI //Eur J Radiol.- 2008, — Vol. P.
- Arrive L., Assayag P., Russ G., Najmark D., Brochet E., Nahum H. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy /Я Comput Assist Tomogr.- 1994, — Vol. 18. P. 376−382.
- Autore C., Quarta G., Spirito P. Risk stratification and prevention of sudden death in hypertrophic- cardiomyopathy //Curr Treat Options Cardiovasc Med.- 2007.- Vol. 9. P. 431−435.
- Bahl O.P., Walsh T.J., Massie E. Electrocardiography- andv vectorcardiography in idiopathic hypertrophic subaortic stenosis //Am J Med Sci.- 1970.- Vol. 259. P. 262−271.
- Basso C.,' Thiene G., Corrado D., Buja G., Melacini P., Nava A. Hypertrophic cardiomyopathy and' sudden death in the young: pathologic evidence of myocardial ischemia //Hum PathoK- 2000.- Vol. 31. P". 988 998.
- Been M., Kean D., Smith M.A., Douglas R.H., Best J.J., Muir A.L. Nuclear magnetic resonance in hypertrophic cardiomyopathy //Br Heart J.- 1985.-Vol. 54. P. 48−52.
- Bogaert J., Dymarkowski S. Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac pathology //Eur Radiol.-2005.- Vol. 15 Suppl 2. P. B52−58.
- Bogaert J., Goldstein M., Tannouri F., Golzarian" J., Dymarkowski S. Original report. Late4 myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging //AJR Am J Roentgenol.- 2003.- Vol*. 180. P. 981−985.
- Bogaert J., Taylor A.M., Van Kerkhove F., Dymarkowski S. Use of inversion recovery contrast-enhanced MRI for cardiac imaging: spectrum of applications //AJR Am J Roentgenol: — 2004.- Vol. 182. P. 609−615.
- Chandra M., Silverman M: E., Oshinski J., PettigrewR. Diagnosis of cardiac sarcoidosis aided by MRI //Chest.- 1996.- Vol. 110. P. 562−565.
- Corrado D., Basso C., Schiavon M., Thiene G. Screening for hypertrophic cardiomyopathy in young athletes //N Engl J Med.- 1998.- Vol. 339. P. 364−369:
- Cosio F.G., Moro C., Alonso M., de la Calzada C.S., Liovet A. The Q waves hypertrophic cardiomyopathy: an electrophysiologic study //N Engl J Med.-1980.- Vol. 302.-P. 96−99.
- Diez J. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease //Circ J.- 2008.- Vol. 72 Suppl A. P. A8-A12.
- Diez J., Lopez В., Gonzalez A., Querejeta R. Clinical aspects of hypertensive myocardial fibrosis //Curr Opin Cardiol.- 2001.- Vol. 16. P. 328−335.
- Dupuis J.M., Victor J., Furber A., Pezard P., Lejeune L.L., Tadei A. Value of- magnetic resonance imaging in cardiac sarcoidosis. Apropos of a case. //Arch Mai Coeur Vaiss.- 1994.- Vol. 87. P. 105−110.
- Edelman R.R. Contrast-enhanced MR imaging of the heart: overview of the literature //Radiology.- 2004.- Vol. 232. P. 653−668.
- Elliott P.M., Gimeno Blanes J.R., Mahon N.G., Poloniecki J.D., McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy //Lancet.- 2001.- Vol. 357. -P. 420−424.
- Elliott P.M., Gimeno J.R., Tome M.T., Shah J., Ward D., Thaman R., Mogensen J., McKenna W.J. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy //Eur Heart J.-2006.-Vol. 27.-P. 1933−1941.
- Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients //J Am Coll Cardiol.- 2000.- Vol. 36. P. 2212−2218.
- Elliott P.M., Sharma S., Varnava A., Poloniecki J., Rowland E., McKenna W.J. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy //J Am Coll Cardiol.- 1999.- Vol. 33.-P. 1596−1601.
- Factor S.M., Butany J., Sole M.J., Wigle E.D., Williams W.C., Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy //J Am Coll Cardiol.- 1991.-Vol. 17.-P. 1343−1351.
- Farmer D., Higgins C.B., Yee E., Lipton M.J., Wahr D., Ports T. Tissue characterization by magnetic resonance imaging in hypertrophic cardiomyopathy //Am J Cardiol.- 1985.- Vol. 55. P. 230−232.
- Feldman A.M., McNamara D. Myocarditis //N Engl J Med.- 2000-- Vol. 343.-P. 1388−1398.
- Ferrans V.J., Morrow A.G., Roberts W.C. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients //Circulation.- 1972, — Vol. 45. P. 769−792.
- Frank H., Globits S. Magnetic resonance imaging evaluation of myocardial and pericardial disease //J Magn Reson Imaging.- 1999.- Vol. 10. P. 617 626.
- Frenneaux M.P., Counihan P.J., Caforio A.L., Chikamori Т., McKenna W.J. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy //Circulation.- 1990.-Vol. 82. P. 1995−2002.
- Frohlich E.D. State of the Art lecture. Risk mechanisms in hypertensive heart disease //Hypertension.- 1999.- Vol. 34. P. 782−789.
- Frohlich E.D. Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease //Braz J Med Biol Res.- 2000.- Vol. 33. P. 693−700.
- Frohlich E.D. Fibrosis and ischemia: the real risks in hypertensive heart disease //Am J Hypertens.- 2001.- Vol. 14. P. 194S-199S.
- Gaudio C., Pelliccia F., Tanzilli G., Mazzarotto P., Cianfrocca C., Marino B. Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy //Clin Cardiol.- 1992, — Vol. 15. P. 164−168.
- Gupta, A., Lee V.S., Chung Y.C., Babb J.S., Simonetti O.P. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging //Radiology.- 2004.- Vol-. 233. P. 921−926.
- Gutberlet M A.H., Hausmann H, et al. Value of Gd-DTPA. «late enhancement» in MRI in comparison with gated SPECT for the assessment of myocardial' viability: initial results in patients with impaired LV-function //Radiology.- 2001.- Vol. 221(P). P.
- Higgins C.B., Byrd B.F., 3rd, Stark D., McNamara M., Lanzer P., Lipton M.J., Schiller N.B., Botvinick E., Chatterjee K. Magnetic resonance imaging in hypertrophic cardiomyopathy //Am J Cardiol.- 1985.- Vol. 55. P. 11 211 126.
- Kellman P., Arai A.E., McVeigh E.R., Aletras A.H. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement //Magn Reson Med.- 2002, — Vol. 47. P. 372 383.
- Kellman P., Larson A.C., Hsu L.Y., Chung Y.C., Simonetti O.P., McVeigh E.R., Arai A.E. Motion-corrected1 free-breathing delayed enhancement imaging of myocardial infarction //Magn Reson Med.- 2005.- Vol. 53. P. 194−200.
- Kim D.H., Choi S.I., Chang H.J./ Choi D.J., Lim C., Park J.H. Delayed hyperenhancement by contrast-enhanced magnetic resonance imaging: Clinical application for various cardiac diseases //J Comput Assist Tomogr.-2006, — Vol. 30. P. 226−232.
- Kim R.J., Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? //J Am Coll Cardiol.- 2003.- Vol. 41. P. 15 681 572.
- Kim R.J., Judd R.M., Chen E.L., Fieno D.S., Parrish T.B., Lima J.A. Relationship of elevated 23Na magnetic resonance image intensity to infarctsize after acute reperfused myocardial infarction //Circulation.- 1999.- Vol. 100. P. 185−192.
- Kofflard M.J., Waldstein D.J., Vos J., ten Cate F.J. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population //Am J Cardiol.- 1993.- Vol. 72. P. 939−943.
- Krombach G.A., Niendorf Т., Gunther R.W., Mahnken A.H. Characterization of myocardial viability using MR and CT imaging //Eur Radiol.- 2007.- Vol. 17. P. 1433−1444.
- Kwong R.Y., Falk R.H. Cardiovascular magnetic resonance in cardiac amyloidosis //Circulation.- 2005.- Vol. 111. P. 122−124.
- Laissy J.P., Messin В., Varenne O., lung В., Karila-Cohen D., Schouman-Claeys E., Steg P.G. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences //Chest.- 2002.- Vol. 122. P. 16 381 648.
- Lee V.S., Resnick D., Tiu S.S., Sanger J.J., Nazzaro C.A., Israel G.M., Simonetti O.P. MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with (99m)Tc sestamibi //Radiology.- 2004.-Vol. 230.-P. 191−197.
- Maceira A.M., Joshi J., Prasad S.K., Moon J.C., Perugini E., Harding I., Sheppard M.N., Poole-Wilson P.A., Hawkins P.N., Pennell D.J. Cardiovascular magnetic resonance in cardiac amyloidosis //Circulation.-2005.-Vol. 111. P. 186−193.
- Mahnken A.H., Gunther R.W., Krombach G. Contrast-enhanced MR and MSCT for the assessment of myocardial viability. //Rofo.- 2006.- Vol. 178. -P. 771−780.
- Mahrholdt H., Wagner A., Judd R.M., Sechtem U., Kim R.J. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies //Eur Heart J.- 2005.- Vol. 26. P. 1461−1474.
- Marian A.J., Roberts R. Recent advances in- the molecular genetics of hypertrophic cardiomyopathy //Circulation.- 1995.- Vol. 92. P. 1336−1347.
- Maron B.J. Q waves in hypertrophic cardiomyopathy: a reassessment //J Am Coll Cardiol.- 1990.- Vol. 16. P. 375−376.
- Maron B.J. Hypertrophic cardiomyopathy //Lancet.- 1997.- Vol. 350. P. 127−133.
- Maron B.J. Cardiology patient pages. Hypertrophic cardiomyopathy //Circulation.- 2002.- Vol. 106. P. 2419−2421.
- Maron B.J. Hypertrophic cardiomyopathy: a systematic review //Jama.-2002.- Vol. 287. P. 1308−1320.
- Maron B.J. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy //Cardiol Rev.- 2002.- Vol. 10. P. 173−181.
- Maron B.J. Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. //Rev Esp Cardiol.- 2006.- Vol. 59. P. 527 530.
- Maron B.J., Anan T.J., Roberts W.C. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy //Circulation.- 1981.- Vol. 63. P. 882−894.
- Maron B.J., Bonow R.O., Cannon R.O., 3rd, Leon M.B., Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1) //N Engl J Med.- 1987.- Vol. 316. P. 780 789.
- Maron B.J., Casey S.A., Poliac L.C., Gohman Т.Е., Almquist A.K., Aeppli D.M. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort//Jama.- 1999.- Vol. 281. P. 650−655.
- Maron B.J., Cecchi F., McKenna W.J. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy //Br Heart J.- 1994.- Vol. 72. P. S13−18.
- Maron B.J., Epstein S.E., Roberts W.C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural' coronary arteries //Am J Cardiol.- 1979.- Vol. 43. P. 10 861 102.
- Maron B.J., Estes N.A., 3rd, Maron M.S., Almquist A.K., Link M.S., Udelson J.E. Primary prevention of sudden death as a novel treatmentstrategy in hypertrophic cardiomyopathy //Circulation.- 2003.- Vol. 107. P. 2872−2875.
- Maron B.J., Lipson L.C., Roberts W.C., Savage D.D., Epstein S.E. «Malignant» hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death //Am J Cardiol. r-1978.-Vol'. 41. P. 1133−1140.
- Maron B.J., Roberts W.C. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy//Circulation.- 1979.- Vol. 59. P. 689−706.
- Maron B.J., Savage D.D., Wolfson J.K., Epstein S.E. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study //Am J Cardiol.- 1981.- Vol. 48. P. 252−257.
- Maron В J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles //Jama.- 1996.- Vol. 276. P. 199−204.
- Maron B.J., Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy //Am J Cardiol.- 1998, — Vol. 81. P. 13 391 344.
- Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz Т., Boriani G., Estes N.A., 3rd, Favale S., Piccininno M., Winters S.L., Santini M., Betocchi S.,
- Arribas F., Sherrid M.V., Buja G., Semsarian C., Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy //Jama.- 2007.- Vol. 298. P. 405−412.
- Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., CecchiF., Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy //N Engl J Med.- 2003.-Vol: 348.-P. 295−303.
- Masui Т., Finck S., Higgins C.B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging //Radiology.- 1992, — Vol. 182.-P. 369−373.
- Matsuki M., Matsuo M. MR findings of myocardial sarcoidosis //Clin Radiol.- 2000.- Vol. 55. P. 323−325.
- Matsunaka Т., Hamada M., Matsumoto Y., Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI //Magn Reson Med Sci.- 2003.- Vol. 2. -P. 61−69.
- McKenna W., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features //Am J Cardiol.- 1981.-Vol. 47. P. 532−538-
- McKenna W.J., Borggrefe M., England D., Deanfield J., Oakley C.M., Goodwin J.F. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study //Circulation.-1982.- Vol. 66. P. 1233−1240.
- McKenna W.J., England D., Doi Y.L., Deanfield J.E., Oakley C., Goodwin J: F. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis //Br Heart J.- 1981.- Vol. 46. P, 168−172.
- McKenna W.J., Franklin- R.C., Nihoyannopoulos Pi, Robinson K.C., Deanfield J.E. A^h^hmia and prognosis indnfants, children and adolescents with hypertrophic cardiomyopathy //J Am Coll Cardiol: — 1988.- Vol: 11. P. 147−153.
- McKenna W.J., Sadoul N., Slade A.K., Saumarez R.C. The prognostic significance of nonsustained ventricular tachycardias in: hypertrophic cardiomyopathy//Circulation.- 1994, — Vol. 90. P. 3115−3117.
- Miller M.A., Gomes J.A., Fuster V. Risk, stratification of sudden cardiac death in hypertrophic cardiomyopathy //Nat Clin Pract Cardiovasc Med.-2007.- Vol. 4. P. 667−676.
- Moon J: C., McKenna W. J, McCrohon J.A., Elliott P.M., Smith G.C., Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance //J Am Coll Cardiol.-2003.- Vol. 41. P. 1561−1567.
- Myerson S.G., Bellenger N.G., Pennell D.J. Assessment of left ventricular mass by cardiovascular magnetic resonance //Hypertension.- 2002.- Vol. 39. P. 750−755.
- Nicod P., Polikar R., Peterson K.L. Hypertrophic cardiomyopathy and sudden death//N Engl J Med.- 1988.- Vol. 318. P. 1255−1257.
- Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., Seidman C.E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly //Circulation.- 2002.- Vol. 105. P. 446−451.
- Olivotto I., Gistri R., Petrone P., Pedemonte E., Vargiu D., Cecchi F. Maximum. left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy //J Am Coll CardioL- 2003.- Vol: 41. P. 315 321.
- Papavassiliu.T., Schnabel P., Schroder M., Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well’with histological findings of fibrosis //Eur Heart J.- 2005.- Vol. 26. P. 2395.
- Rickers C., Wilke N.M., Jerosch-Herold M., Casey S.A., Panse P., Panse N., Weil’J., Zenovich A.G., Maron B.J. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy //Circulation.-2005, — Vol. 112. P. 855−861.
- Sadoul N., Prasad K., Elliott P.M., Bannerjee S., Frenneaux M.P., McKenna W. J: Prospective prognostic assessment of blood pressure response duringexercise in patients with hypertrophic cardiomyopathy //Circulation.- 1997.-Vol. 96.-P. 2987−2991.
- Schulz-Menger J., Strohm O., Dietz R., Friedrich M. G: Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging //Magma.- 2000.- Vol. 11. P. 82−83.
- Schwartz K., Carrier L., Guicheney P., Komajda M. Molecular basis of familial cardiomyopathies //Circulation.- 1995.- Vol. 91. P. 532−540.
- Shah et ah In: Edelman RR e.a., eds. Clinical Magnetic Resonance Imaging, 3rd ed. //New York: Elsevier Press.- 2005.- Vol.- P:
- Silka M.J., Kron J., Dunnigan A., Dick M., 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society //Circulation.- 1993.- Vol. 87. P. 800 807.
- Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis //Circulation.- 1978.- Vol. 58. P. 1204−1211.
- Simonetti O.P., Kim R.J., Fieno D.S., Hillenbrand H.B., Wu E., Bundy J.M., Finn1 J.P., Judd R.M. An improved MR imaging technique for the visualization of myocardial infarction //Radiology.- 2001.- Vol. 218. P.1 215−223.
- Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., Maron B.J. Magnitude-of left ventricular hypertrophy and risk of sudden -death in hypertrophic cardiomyopathy //N EngbJ Med.- 2000.- Vol. 342. P. 17 781 785.
- Spirito P., Chiarella F., Carratino L., Berisso M.Z., Bellotti P., Vecchio C. Clinical' course and prognosis of hypertrophic cardiomyopathy in an outpatient population //N Engl J Med.- 1989.- Vol. 320. P. 749−755.
- Spirito P., Maron B.J. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment //Circulation.- 1983.-Vol. 67. P. 1100−1108.
- Spirito P., Maron B.J. Sudden death and hypertrophic cardiomyopathy //Lancet.- 2001.- Vol. 357. P. 1975−1976.
- Spirito P., Maron B.J., Bonow R.O., Epstein S.E. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy //J Am Coll Cardiol.- 1986.- Vol. 8. -P. 537−544.
- Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy //N Engl J Med.- 1997.- Vol. 336. P. 775 785.
- Tanaka M., Fujiwara H., Onodera Т., Wu D.J., Hamashima Y., Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy //Br Heart J.- 1986.- Vol. 55. P. 575 581.
- Varnava A.M., Elliott P.M., Mahon N., Davies M.J., McKenna W.J. Relation between myocyte disarray and outcome in hypertrophic-cardiomyopathy //Am J Cardiol.- 2001.- Vol. 88. P. 275−279.
- Vignaux O., Dhote R., Duboc D., Blanche P., Dusser D.,. Weber S., Legmann P. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study //Chest.-2002.-Vol. 122.-P. 1895−1901.
- Virmani R., Bures J.C., Roberts W.C. Cardiac sarcoidosis- a major cause of sudden death in young individuals //Chest.- 1980.- Vol. 77. P. 423−428.
- Vogel-Claussen J., Rochitte C.E., Wu K.C., Kameri.R., Foo Т.К., Lima J.A., Bluemke D.A. Delayed enhancement MR imaging: utility in myocardial assessment //Radiographics.- 2006.- Vol. 26. P. 795−810.
- Wigle E.D., Heimbecker R.O., Gunton R.W. Idiopathic ventricular septal' hypertrophy causing muscular subaortic stenosis //Circulation.- 1962.- Vol. 26. P. 325−340.
- Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction //Lancet.- 2001.- Vol. 357. P. 21